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Cellular Action of Vasopressin in Medullary Tubules of
Mice with Hereditary Nephrogenic Diabetes Insipidus
BRIAN A. JACKSON, RICHARD M. EDWARDS, HEINZ VALTIN, and THOMAS P. DOUSA,
Nephrology Research Laboratories, Mayo Clinic and Foundation, Mayo Medical
School, Rochester, Minnesota 55901; and Department of Physiology, Dartmouth
Medical School, Hanover, New Hampshire 03755
A B S T R A C T Our previous studies (1974. J. Clin.
Invest. 54: 753-762.) suggested that impaired metabo-
lism ofcyclic AMP (cAMP) may be involved in the renal
unresponsiveness to vasopressin (VP) in mice with
hereditary nephrogenic diabetes insipidus (NDI). To
localize such a defect to specific segments of the
nephron, we studied the activities of VP-sensitive
adenylate cyclase, cAMP phosphodiesterase (cAMP-
PDIE), as well as accumulation ofcAMP in medullary
collecting tubules (MCT) and in medullary thick as-
cending limbs of Henle's loop (MAL) microdissected
from control mice with normal concentrating ability
and from mice with hereditary NDI.
Adenylate cyclase activity stimulated by VP or by
NaF was only slightly lower (-24%) in MCT from NDI
mice, compared with controls. In MAL of NDI mice,
basal, VP-sensitive, and NaF-sensitive adenylate
cyclase was markedly (> -60%) lower compared with
MAL of controls. The specific activity of cAMP-PDIE
was markedly higher in MCT of NDI mice compared
with controls, but was not different between MAL of
control and NDI mice. Under present in vitro condi-
tions, incubation of intact MCT from control mice with
VP caused a striking increase in cAMP levels (>10),
but VP failed to elicit a change in cAMP levels in MCT
from NDI mice. When the cAMP-PDIE inhibitor 1-
methyl-3-isobutyl xanthine (MIX) was added to the
above incubation, VP caused a significant increase in
cAMP levels in MCT from both NDI mice and control
mice. Under all tested conditions, cAMP levels in MCT
of NDI mice were lower than corresponding values
in control MCT. Under the present experimental
setting, VP and other stimulating factors (MIX, cholera
Results were presented in part at the joint Japan-U. S. A.
seminar "Biosynthesis, Secretion and Mechanism ofAction of
Vasopressin," Nikko, Japan, September 1979, and at the Fall
American Physiologist Society meeting, October 1979, New
Orleans, La. 1979. Physiologist. 22: 33.
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toxin) did not change cAMP levels in MAL from either
control mice or from NDI mice.
The results of the present in vitro experiments sug-
gest that the functional unresponsiveness of NDI mice
to VP is perhaps mainly the result of the inability of
collecting tubules to increase intracellular cAMP levels
in response to VP. In turn, this inability to increase
cAMP in response to VP is at least partly the result of
abnormally high activity of cAMP-PDIE, a somewhat
lower activity of VP-sensitive adenylate cyclase in
MCT of NDI mice, and perhaps to a deficiency of
some other as yet unidentified factors. The possible
contribution of low VP-sensitive adenylate cyclase ac-
tivity in MAL of NDI mice to the renal resistance
to VP remains to be defined.
INTRODUCTION
One animal model that phenotypically closely re-
sembles human hereditary nephrogenic diabetes in-
sipidus (NDI)l is a strain of mouse (so-called DI +/+
severe) with an inherited, vasopressin (VP)-resistant
urinary concentrating defect (1-4). Because ad-
ministration of VP to NDI mice fails to increase
osmolality of hypotonic urine (2, 3), these functional
features indicate that collecting tubules failed to in-
crease water permeability in response to the hormone.
It is well established that the hydroosmotic effect of
VP in collecting tubules (5-8) is mediated by adeno-
sine 3',5'-cyclic monophosphate (cAMP) (5-7), and
we have previously investigated the possibility that
unresponsiveness to VP in NDI mice might be the
'Abbreviations used in this paper: AVP, [8-arginine]-
vasopressin, cAMP-PDIE, cAMP phosphodiesterase;
Gpp(NH)p, 5'-guanylimidodiphosphate; GTP, guanosine 5'-
triphosphate; MAL, medullary thick ascending limb of
Henle's loop; MCT, medullary collecting tubule; MIX, 1-
methyl-3-isobutyl xanthine; NDI, nephrogenic diabetes
insipidus; RIA, radioimmunoassay; VP, vasopressin; %A,
relative.
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result of a defect in VP-dependent cAMP metabolism
(4, 9, 10).
In our previous studies (4), we investigated several
known (or hypothetical) biochemical components in-
volved in the cellular action ofVP in a cell-free system
(4). In washed membrane fractions prepared from the
renal medulla (outer and inner medulla taken together),
stimulation of adenylate cyclase by VP was lower in
preparations from NDI mice than from control mice
with an intact urinary concentrating mechanism (4).
Because the responsiveness of renal medullary ade-
nylate cyclase to VP in NDI mice was diminished but
not absent, it remained an open question whether such
a partial deficiency could be the cause of complete
ftunctional unresponsiveness to VP (9, 10).
Current advances in methodology now enable us to
determine the activity of adenylate cyclase (11), cAMP
phosphodiesterase (cAMP-PDIE) (12), and cAMP con-
tenit (13, 14) in individual segmenits of the nephron.
In most mammnalian species, including mice (15),
VP-sensitive adenylate cyclase was found not only in
collecting tubules and ducts, as expected, but also in
the ascending limb of Henle's loop (16). Although the
function ofVP (and by extension, of the VP-dependent
cAMP system) in the ascending limb of Henle's loop
is not yet established, recent observations suggest that
VP stimulates solute transport out ofthe lumen of thick
medullary ascending limbs of Henle's loop, at least in
the mouse and rat kidney (16-19), thus enhancing dilu-
tion of tubular fluid and build-up of solute gradient
in the interstitium.
To define and localize defects in the cellular
action of VP in NDI mice, we have now investigated
key components of VP-sensitive cAMP metabolism in
two distinct sites of VP action, namely, the medullary
collecting tubules (MCT) and the medullary thick
ascending limb of Henle's loop (MAL). These two
nephron segments were microdissected from the outer
medulla of mice with hereditary NDI, and control
mice with intact urinary concentrating function.
The results have revealed several specific alterations
in VP-dependent cAMP metabolism in MCT and MAL
of NDI mice; these alterations may be the biochemical
basis for the resistance of NDI mice to the anti-
diuretic effect of VP in vivo.
METHODS
Experimental animals were adult mice of either sex. As in
our previous study (4), the so-called DI +/+ severe strain of
mice with fully expressed NDI (2-4) were compared with the
the VII +/+ strain, which have normal concentrating ability
and serve as controls. These two strains are subse-
quently referred to in the text as "NDI mice" and "control
mice," respectively. All animals were raised in the Depart-
ment of Physiology, Dartmouth Medical School (Hanover,
N. H.) under conditions identical to those thoroughly de-
scribed in our previous communication (4). After shipment
by air to Rochester, Minn., and before experimentation, all
animals were maintained for at least 10 d in an air-condi-
tioned room (21°-250C) and allowed free access to tap water
and standard diet (Purina Laboratory Rat Chow, Ralston
Purina Co., St. Louis, M. 0.). Urine osmolality of control
mice ranged around 2,500 mosmol/kg H20 (3, 4), whereas that
ofNDI mice averaged 217+28 mosmol/kg H20 (mean±SEM);
in fact, each DI +/+ severe animal was classified in Hanover,
N. H., on the basis of its genetic background and the
fact that it excreted urine that was hypotonic to plasma.
Preparation of tissue samples. Tubular segments were
prepared from control and NDI mice using the procedure
described in principle by Morel et al. (11), with several minor
modifications. Mice were lightly anesthetized with pheno-
barbital (12 mg/100 g body wt) and the aorta was cannulated
retrogradely with polyethylene PE-10 tubing (Clay Adams,
Div., Parsippany, N. J.), the tip being placed just distal to the
branching of the left renal artery. Both kidneys were per-
fused to complete blanching with 10 ml of heparinized
(heparin concentration 20 USP U/ml) "collagenase me-
dium" (composition specified below) at the rate of 1 ml/
min. After the perfusion, both kidneys were quickly re-
moved and sliced with a razor blade along the cortico-
medullary axis. The slices were then incubated in aerated
collagenase medium at 35°C for 25 min. After incubation,
the slices were thoroughly rinsed in ice-cold "microdissection
medium" (composition given below) and transferred to Petri
dishes for microdissection. All subsequent steps, including
microdissection, were performed at 0°-4°C. Segments ofMAL
and MCT, 0.5-1.0 mm long, were carefully teased out from the
inner stripe of the outer medulla with sharpened steel
needles using a stereomicroscope (magnification 30x). MAL
and MCT were identified using the criteria described by
Morel et al. (11, 20). In general, MAL have smooth sharp
walls, whereas MCT appear granular and have irregular
borders. In addition, the MAL frequently has a segment of
thin ascending limb attached to it, which also aids in identifi-
cation. The thin segment is cut offbefore transfer. Appearance
of tubules from NDI mice was similar to that of controls,
except that MCT appeared slightly distended in some
nephrons from NDI mice. The external diameters of tubules
were determined from photographs. MAL from control and
NDI mice did not differ in external diameter; however,
outer diameters of MCT from NDI mice were significantly
greater than those from control mice (Table I). Dissected
segments were aspirated in a small droplet of microdissec-
tion medium and transferred either directly onto concave bac-
teriological slides or onto small fragments (-3 mm2) of glass
cover slip, depending upon the assay to be performed. In
general, two to three segments of MCT or MAL were pooled
(combined length up to 2-3 mm) in <1 ul of microdissec-
tion medium to constitute one sample. All the samples of
tubule segments were then photographed (magnification 40x)
and tubule lengths were measured from photographs using
a planar measure. After the segments were photographed,
samples were kept at 0°-4°C before incubations or assays to
be performed immediately, or before freezing for storage.
Assays
To minimize day-to-day variations between assays and pre-
parative procedures, and to allow paired comparisons where
appropriate, tubules from control and NDI mice were dis-
sected, incubated, and assayed simultaneously. Likewise,
when the actions of hormones and drugs were studied,
tubules from the same animal were incubated with or with-
out test agents within the same experiment.
Enzyme assays. Because tubular cells are, in general, rela-
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TABLE I
External (Outer) Tubular Diameter and Protein Content
of MCT and of MAL from Normal (Control)
Mice and Mice with NDI
Conitrol iice NI)I niice P value*
External tubular
diamneter, ,AnI
MCT 32.9±0.6t 43.6±0.6 <0.001
(33) (38)
NIAL 23.7±0.5 24.6±0.6 NS
(43) (30)
Protein conitenit,
W/)In In
MCT 0.09 + 0.005t 0.13±0.009 <0.001
(25) (27)
MAL 0.10±0.006 0.12±0.006 <0.025
(30) (35)
* For significancie ofdifference between conitrol mice and NDI
mice; t test.
+ Denotes mean±SEM; number of samples is indicated in
parentheses.
tivelv impermeable to nucleotides (11), thev were first dis-
rupted before enzyme assays (adenylate cyclase, cAMP-
PDIE) b1 a comibination of freezing and hypoosmotic shock
(11). The microdissection mediumii was aspirated from each
sample and replaced with 0.5 ,ud "hypoosmiotic medium"
(composition given below). All samples were then frozen
rapidly by placing them on a block of dry-ice and stored at
-800C overnight. Before assay, samples were allowed to
thaw at 40C and then used for determinationis of enzyme
activities.
Adenylvate cyclase activity was meeasured according to a
modification of the method of Morel et al. (11, 20, 21).
Samples of tubules (0.1-0.2 ,ug protein/saample) were incu-
bated at 30°C for 30 min in a final volume of 5.5 gul consisting
of the following (final concentrations): 0.25 mM [a32-P]ATP
(5-6 x 106 cpm/sample), 1 mM cAMP, 3.8 mnM MgCl2, 0.25
mM EDTA, 100 mM Tris HCI, 20 mM creatine phosphate,
and 1 mg/ml creatine kinase, pH 7.4, with or without addi-
tion of hormones or other test substances as appropriate. The
reactioin mixture was sealed water-tight between two vaseline-
coated concave slides and immersed in a constant temperature
water bath (11, 20, 21). The reaction was stopped by addition
of 150 ,ul "stop solution" consisting of 3.3 mM ATP, 5 mM
cAMP, 50 mlM Tris HCl (pH 7.6), and [3H]cAMP (8 x 103
cpm/samiiple; to determine recovery). Products vere separated
according to the method of Salomnon et al. (22) using Dowex-
50 and alutmlinum oxide columns (Dow Chemical Co.,
Midland, Mich.); average recovery of cAMP was 61.4±0.4%.
Specific activity of adenylate cyclase was expressed in
femtomoles ofcAMP formed per 30 min, either per millimeter
of tubule length, or per microgramii of tubular protein.
cAMP-PDIE activity was measured using an assay system
employed previously for glomeruli and mixed cortical tubules
(22), but adapted for small sample size (12). Tubular segments
(0.1-0.2 jxg protein/sample) were pretreated by freezing in
hypoosmnotic medium as described above for adenylate
eyclase. Samnples were incubated for 10 min at 37°C in a final
volume of 5 gxl consisting of' 10 mnM MgSO4, 0.1 iM EDTA,
50 mM Tris HCl, pH 8.0 (Mg-EDTA-Tris buffer), with a
final substrate concentration of 1 ,uM [3H]cAMP (3 x 105 cpm).
The reaction was terminated by addition of two successive
50-gl aliquots of Mg-EDTA-Tris buffer, which were quickly
transferred to glass test tubes (12 x 75 mm). All test tubes
were immediately immersed in a boiling water bath for 3 min.
Tubes were then cooled by placing them on ice and 50 ,ul of
5'-nucleotidase (rattlesnake venom from Crotalus atrox; 1
mg/ml) was added to each tube and incubated for a further
15 min at 37°C, as in our previous studies (7, 23). Nucleo-
tides were separated from nucleosides on QAE-Sephadex
columns (7, 23) as described by Wells et al. (24).
In preliminary experiments it was determined that, under
the conditions described above, cAMP hydrolysis is linearly
proportional to tubular length (up to at least a total of 3 mm/
sample) and also linearly proportional to time (up to at least
20 min). This applies both for MCT and MAL from either
control or NDI mice. Consequently, specific activity ofcAM P-
PDIE was expressed in femtomoles of cAMP hydrolyzed per
min, either per millimeter of tubule length, or per micogram
tubular protein. cAMP-PDIE was not affected by storage for
24 h at -800C.
Incubation of tubules for determination of cAMP content.
When testing the effect of hormones and drugs on cAMP
accumnulation, freshly dissected tubular segments (3-4 mm
pooled total length per one sample; more than needed for
enzyme assay) were placed on fragments of glass cover slips
(-3 mm2) that were placed on concave bacteriological slides
and photographed. The microdissection medium was as-
pirated from samples with a micropipette and replaced with
2.0 ,lI of "modified Krebs-Ringer buffer" (composition given
below) with or without hormone and/or drugs. While still on
fragments of glass coverslip, the samples were then sealed
water-tight between two vaseline-coated concave bacterio-
logical slides and incubated in a water bath at 300C for 20 min.
In each experiment, samples of MCT and MAL from both
control and NDI mice were always incubated at the same
time and under exactly the same conditions. At the end of the
incubation period, the reaction was stopped by placing the
slides with samples on a block of dry ice. This procedure
causes instant freezing (<1 s) mainly because of the small
sample mass; consequently, use of precooled stainless steel
clamps and liquid N2, required for larger amounts of tissue
(25), is not necessary. The samples, still frozen on glass cover
slip fragments, were quickly transferred with forceps into the
bottom of polyethylene radioimmunoassay (RIA) tubes (12
x 75 mm) and 50 ,lI of 5 mM HCl was added. The tubes
were immediately placed in a boiling water bath for 5 min,
then cooled, and 50 ,pl of 100 mM sodium acetate buffer (pH
6.2) was added to each tube. The samples were then frozen
and stored at -200C for up to 24 h, until assayed for cAMP con-
tent by RIA.
Determination of cAMP content. The content of cAMP
was determined by RIA as described in detail in our recent
communications (26, 27). Samples, dissolved in acetate buf-
fer (see above), and cAMP standards were first acetylated
as described by Frandsen and Krishna (28), in a way analogous
to our previous study (26). Acetylated samples and cAMP
standards were incubated with anti-cAMP antibodies and
1251-succinyl-cyclic AMP methyl-ester for 16-24 h at 40C.
Free and bound antigens were separated by centrifugation at
7,000 g for 20 min (26, 27). Radioactivity of the samples
was counted in a Searle analytical gamma counter, model
1285 (Searle Radiographics Inc., Des Plaines, Ill.). The spe-
cificity and validity of this modification of the RIA were
detailed in our recent report (26). Because tubules were
transferred to RIA tubes together with the incubation medium,
cAMP content represents the sum of cAMP contained in
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tubular cells plus that which leaked into the incubation
nmediumil. Recovery of cANP can be assumed to be complete
because the tubules were transferred from incubation chain-
bers directly into the RIA test tubes along with the fragments
of cover slips on wvhieh they were incubated, and all sub-
sequent steps (solubilization, acetylationi, and RIA) were
performed in these tubes.
Expression and evaluiatiorn of results. In most previous
studies on adenylate cyclase activity in tubular segmenits,
results were expressed per unlit length of the tubule (11, 15,
16, 20, 21). It is -possible, however, that enzyme activities
or cAMP levels, when corrected for protein conitent, may more
closel) reflect the situation in vivo, especially because pro-
tein content and, in the case of MCT also, outer diameter
differ between control and NDI mice (Table I). Therefore,
results have been presented both per millimeter tubular
length (in the tables) anid per micogram of protein in the
samnple (in the figures). The latter was calculated by mutlti-
plying the number of millimeters of total pooled tubular
length in the sample by the appropriate factor for protein
content (microgram per millimeter), as listed in Table I.
Because protein and enzyme activities or cAMP content
cannlot be measured in the same tubule sample, the average
proteini content per unit length was determined on a separate
series of MAL and MCT. Frozen mierodissected tubule
samples were dissolved in 10 Al of 1% sodium dodecyl
sulfate (7,23,26,27), and protein content was detennined by a
modification of the colorimetric method of Lowry (29),
similar to that used for protein determination in micropunc-
ture samples (30). Final volume was 90 jAl; using this modifi-
cation for very small samples, quantities as low as 0.2 jxg
protein/sample could be accurately determined.
As in rat kidney (12, 13), in both mouse MCT and MAL
the protein content was directly proportional to tubule length.
Tubule length correlated with protein content in MCT (r
= 0.68+0.14; P < 0.001) and for MAL (r = 0.73+0.105; P
< 0.001). Protein content per millimeter of MAL is almost
identical to that detected in rat kidney MAL (13) and to the
value reported for rabbit MAL (11). Likewise, the protein
content of mouse MCT was similar to that of rat MCT (13)
and lower than the protein content reported for rabbit cortical
collecting tubules (11, 31). The outer diameter of MCT was
larger than that of MAL (Table I); the difference was less
than that reported for rat nephron (32). Both the outer
diameter and protein content of MCT was significantly
higher in NDI mice (Table I).
The data were evaluated statistically by t test for either
paired or group comparisons as appropriate, and as specified
under Results. P values > 0.05 were considered to be
nonsignificant.
Solutions and materials
The microdissection medium was a modified Hank's solu-
tion, basically as described by Imbert et al. (19), consisting of
(in final concentrations): 137 mM NaCl, 5 mM KCI, 0.8 mM
MgSO4, 0.33 mM Na2HPO4, 1.0 mM MgCl2, 10 mM Tris-HCl,
0.25 mM CaCl2, pH 7.4. The composition of the collagenase
medium was identical to that of the microdissection medium
except that the CaCl2 concentration was 1 mM and it included
collagenase (0.1% wt/vol) and bovine serum albumin (0.1%
wt/vol). The hypoosmotic medium contained (in final con-
centrations): 1 mM MgCl2, 0.25 mM EDTA, 0.1% bovine
serum albumin (wt/vol), and 1 mM Tris-HCl, pH 7.4. Modified
Krebs Ringer buffer contained 140 mM NaCl, 5 mM KCl,
1.2 mM MgSO4, 0.8 mM CaCl2, 10 mM sodium acetate,
10 mM glucose, 20 mM Tris, 2.0 mM NaH2HPO4, pH 7.4.
Materials. Bovine serum albumin, rattlesnake venom
(Crotalus atrox), guanosine 5'-triphosphate (GTP), and cAMP
were purchased from Sigma Chemical Co., St. Louis, Mo.;
collagenase (type I, 125-250 U/mg) was purchased from
Worthington Biochemical Corp., Freehold, N. J.; sodium
heparin (Panheprin, 1,000 USP U/ml) from Abbott Labora-
tories, Chemical Div., North Chicago, Ill.; [a-32P]ATP (25
Ci/mM) was purchased from ICN Nutritional Biochemicals,
Cleveland, Ohio; [3H]cAMP (30-50 Ci/mM) from New
England Nuclear, Boston, Mass. Synthetic 8-arginine-VP
(385 U/mg) and MIX were purchased from Calbiochem-
Behring Corp., American Hoechst, San Diego, Calif.; RIA
kits for the measurement ofcAMP content, cholera toxin, and
5'-guanylimidodiphosphate (Gpp(NH)p) were purchased
from Schwartz/Mann Div., Becton, Dickinson & Co., Orange-
burg, N. Y. These and all other compounds and reagents
were of the highest quality available from standard suppliers.
RESULTS
Adenylate cyclase. When expressed per tubular
protein content, basal activities of adenylate cyclase
in MCT and MAL were significantly lower in NDI
mice than in controls (Fig. 1). The differences were
less prominent when expressed per tubule length, and
reached statistical significance between control and
NDI mice only for MAL (Table II).
Adenylate cyclase in MAL and MCT was markedly
stimulated by [8-arginine]-VP (AVP), as well as by non-
hormonal agents NaF and Gpp(NH)p in both control
and NDI mice. AVP stimulated adenylate cyclase in a
dose-dependent manner; maximal stimulation was
reached at a concentration of -1 sM AVP in both
tubular segments as well as in both control and NDI
0
0
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C
qq
og
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200 r
100 F-
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FIGURE 1 Basal adenylate cyclase activity in MCT and MAL
in normal, control (C) mice and mice with NDI. Enzyme ac-
tivity is expressed in femtomoles of cAMP per 30 min per
microgram of protein. Each bar represents the mean+SEM;
numbers in parentheses at bottom ofbars indicate the number
of animals; the value for each animal is the mean of four
to six samples. O, control mice; 1, NDI mice; *, values
significantly- lower than corresponding values in control
mice (P < 0.01 or higher level of significance; t test).
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TABLE II
Basal Adenylate Cyclase Activities in MCT and MAL
from Normal (Control) Mice and Mice with NDI
Control mice NDI mice P value*
MCT 18.9±2.2t 15.1±+ 1.9 NS
(10) (9)
MAL 19.1 ± 1.6 9.4+0.7§ <0.001
(10) (9)
Enzyme activity is expressed in femtomoles cAM1P per 30
min per millimeter tubule length.
* For significance of difference between control and NDI
mice; t test.
t Denotes mean+SEM; number of experiments is indicated
in parentheses; value in each experiment is based on mean
from four to six samples.
§ Significantly different fromn MCT value of NDI mice (P
< 0.02; t test).
mice (Fig. 2). The half-maximal stimulation was
achieved in all tubule segments at - 10 nM AVP in both
control and NDI mice (Fig. 2).
When expressed per tubule length (Table III), the
stimulation of adenylate cyclase by 1 ,uM AVP in
MCT was not significantly different between control
and NDI mice, whether expressed in absolute (net
increase) or relative (percent increase over basal value)
terms (Table III). When expressed per tubular pro-
tein, however, the increase in adenylate cyclase activity
in response to a maximal dose of AVP was slightly but
significantly lower (by - -24%) in NDI mice than in
controls; relative (%A) stimulation by AVP was not dif-
e.
0
0
0.
0L
ferent between NDI and controls (Fig. 3, right panel).
Lower activity of AVP-stimulated adenylate cyclase in
MCT of NDI mice when expressed per tubule protein
was apparent over the whole range of AVP concentra-
tions tested (Fig. 2, right panel). Incubation with 10
mM NaF stimulated adenylate cyclase in MCT of both
control and NDI mice > 10-fold (Table IV). The in-
crease tended to be lower in NDI mice than in con-
trols, but the difference was not statistically significant
within a given number of experiments (Table IV). A
similar pattern of NaF-stimulated activities appeared
when expressed per tubular protein (data not shown).
When assayed under the same conditions, the
stimulation of adenylate cyclase by AVP was markedly
lower (>60%) in MAL of NDI mice compared with
controls. This profound difference was highly signifi-
cant, regardless of whether the results were expressed
per tubular length (Table III) or per tubular protein
(Fig. 3, left panel). The %A AVP-induced increase
in adenylate cyclase activity tended to be slightly lower
in NDI mice than in controls; however, the difference
was small and not statistically significant (Table III).
The reduced stimulation of adenylate cyclase in MAL
of NDI mice was apparent over a wide range of AVP
concentrations (Fig. 2, left panel). Incubation with 10
mM NaF (Table IV) increased adenylate cyclase > 20
times in MAL of both control and NDI mice. This
stimulation was, however, significantly lower in NDI
than in controls, either when expressed per tubule
length (Table IV) or per tubule protein (data not
shown). The %A increase of adenylate cyclase activity
in response to NaF was not significantly different be-
tween control and NDI mice.
MAL MCT
7000
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I" L . 0 1VII a---I I
0 106
- 10-610a7e 0 10-8 10-7 10-6 10i-
L8-arg] - vasopressin (M)
FIGURE 2 Adenylate cyclase activity in response to various concenltrations ofAVP in MCT (right
panel) and in MAL (left panel) of normal (control) mice and mice with NDI. Enzyme activity is
expressed in femtomoles ofcAMP per 30 min per microgram of protein. Each point represents the
mean+SEM of6-10 samples. The difference in AVP-sensitive adenylate cyclase activity betweeni
control and NDI mice in this particular experiment was quantitatively more pronounced comil-
pared with the average differences (Table III, Fig. 3). , control mice; -- -, NDI mice.
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TABLE III
Effect of I pM AVP on Adenylate Cyclase Activity in MCT and in MAL from Normal (Control) Mice and Mice with NDI
Control mice NDI mice
Experiment Basal 1 AM AVP A(AVP-basal) %A Basal 1 MuM AVP A(AVP-basal)
MCT
1 9.1±0.9* (5) 244.9±15.9 (6) 235.8 2,591 12.5±0.7 (6) 242.5±29.7 (6) 2.30.0 1,840
2 9.9±1.1 (6) 225.8±10.2(6) 215.9 2,180 9.6±1.1 (6) 233.6±17.5(6) 224.0 2,333
3 16.4± 1.2 (6) 237.0±19.1 (5) 220.6 1,345 12.2±1.1 (5) 292.4±22.0 (6) 280.2 2,296
4 21.9±1.3 (4) 247.0±6.3 (5) 280.2 1,027 14.3±1.1 (4) 268.0±22.0 (3) 253.7 1,774
Mean±SEM 14.3±3.0 238.6±4.8 224.3±4.2t 1,786±362t 12.1±0.9 259.1±13.2 246.9±12.81 2,061±147t
MAL
1 10.7±1.4 (6) 434.2±29.1 (6) 432.5 3,957 8.6±0.7 (5) 188.9±20.0 (6) 180.3 2,096
2 10.8±0.9 (6) 392.7±28.4 (6) 381.9 3,536 8.4±0.3 (5) 204.5±14.2 (6) 196.1 2,334
3 19.1±1.1 (6) 331.4±15.4 (6) 312.0 1,635 8.9±0.6 (6) 204.7±9.2 (5) 195.8 2,200
4 24.9±3.7 (4) 421.8±5.1 (4) 396.9 1,593 7.2±1.1 (4) 148.9±12.4 (5) 141.7 1,968
Mean±SEM 16.3±3.4 395.0±22.9 378.5±23.8t 2,680+621t 8.3±0.4 186.7±13.1§ 178.4±12.81§ 2,149±77t
Enzyme activity is expressed in feintomoles cANIP per 30 min per millimeter tubule length.
* Denotes mean+SEM; number of samples is inidicated in parentheses.
(Denotes significant increase (P < 0.025 or higher level of significance; paired t test).
Denotes values significanitly different from corresponding value in control mice (P < 0.01, t test).
The effects of Gpp(NH)p on adenylate cyclase were
also explored in both MCT and MAL, and the pattern
of responses in NDI and control mice was similar to
that for NaF and AVP. In both MCT and in MAL, 0.1
mM Gpp(NH)p stimulated adenylate cyclase more than
10 times in both types of animal (data not shown). In
MAL, adenylate cyclase activity stimulated by
Gpp(NH)p was markedly lower in NDI mice than in
controls; for MCT, the net increase was slightly lower
in NDI than controls, but the %A increase was similar.
The pattern of findings was similar when expressed
per tubular length or per tubular protein.
It was recently reported (33) that adenylate cyclase
activity in the renal cortex had a higher dependency
on GTP in the kidney of a pseudohypoparathyroid
patient than in a normal kidney (33); therefore, we
explored whether this factor might account for dif-
ferences in adenylate cyclase activities in tubules of
NDI and control mice. Addition of 10 ,IM GTP had
no effect on either basal or AVP-stimulated adenylate
cyclase in MCT or MAL of either control or NDI
mice (data not shown).
cAMP-PDIE. In control (normal) mice the activity
ofcAMP-PDIE was not significantly different between
MCT and MAL (Table V); nor was the cAMP-PDIE
activity in MAL of NDI mice significantly different
from the activity in MAL of control mice (Table V, Fig.
4, left panel). On the other hand, cAMP-PDIE ac-
tivity in MCT was markedly higher in NDI mice than
in MCT of controls (Table V, Fig. 4, right panel).
This difference in cAMP-PDIE activity was highly sig-
nificant regardless of whether it was expressed per
TABLE IV
Effect of 10 mM NaF on Adenylate Cyclase Activity in MCT and MAL from Normal (Control) Mice and Mice with NDI
Conitrol mice NDI mice
Experiment Basal 10 mMl NaF A(NaF-basal) %/ Basal 10 mM NaF A(NaF-basal) %A
MCT
1 17.3± 1.3* (5) 170.5±10.6 (4) 153.2 885 12.4±1.0 (5) 153.9±6.5 (5) 141.5 1,141
2 21.9±1.3 (5) 298.4±30.7 (5) 276.5 1,262 14.3±1.1(4) 185.8±12.8 (4) 171.5 1,199
3 25.3±3.1 (6) 351.2±24.2 (5) 325.9 1,288 16.1±4.1 (5) 265.9±26.1 (5) 249.8 1,551
Mean±SEM 21.5±2.3 273.3±53.6 251.9±51.3t 1,145±130t 14.3±1.1 201.9±33.3 187.6±32.31 1,297±128t
MAL
1 18.1±3.3 (4) 486.4±22.5 (4) 468.3 2,587 8.2±0.8 (5) 275.9±20.6 (5) 267.7 3,264
2 24.9±3.7 (4) 634 6±26.7 (4) 609.7 2,448 7.2±1.1 (4) 249.4±19.1 (4) 242.2 3,363
3 20.7±4.6 (5) 691.3+39.7 (5) 670.6 3,239 14.8±1.4 (5) 352.9±40.2 (4) 338.1 2,284
Mean±SEM 21.2±1.9 604.1±61.0 582.8±59.9t 2,758±243t 10.1±2.4 292.7±31.0§ 282.6-28.7t§ 2,971±344t
Enzyme activity is expressed in femtomoles cANIP per 30 min per millimeter tubular length.
* Denotes mean±SEM; numiiber of samples is indicated in parentheses.
(Denotes significant increase (P < 0.05 or higher level of significance; paired t test).
§ Denotes values significantly different fromn corresponding value in control mice (P < 0.02; t test).
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FiGuRE 3 Stimulation of adenylate cyclase activity by AVP in MCT (right panel) and NIAL (left
panel) of normal (control) mice and mice with NDI. Enzyme activity is expressed in femtomoles
of cAMP per 30 min per microgram of protein. B, basal activity; AVP, activity in the presence of
1 tiM AVP. Each bar represents mean+SEM from four animals; the value for each animal is the mean
of four to six samples. O, control mice; 3, NDI mice. AVP-stimulated adenylate cyclase in MAL
of control mice is significantly higher (P < 0.005; t test) than in MCT of control mice. AVP-
stimulated adenylate cyclase activity in MCT of NDI mice is significantly higher (P < 0.05; t test)
than in MAL of NDI mice. AVP-stimulated adenylate cyclase activities of both MAL and MCT
of control mice are significantly higher (P < 0.005, or higher degree of significance; t test) than in
the corresponding segments in NDI mice.
tubule length (Table V) or per tubule protein (Fig.
4, right panel).
Accumulation of cAMP in intact MCT and in MAL.
To determine how the differences in adenylate cyclase
and cAMP-PDIE between control and NDI mice de-
scribed above are reflected in cAMP levels in tubular
epithelial cells, cAMP accumulation (basal and in re-
sponse to AVP or other agents) was examined in freshly
isolated intact tubules. Tubule segments were incu-
bated in a medium either with or without AVP (and
other agents) as described in detail in Methods.
When MCT segments from control mice were incu-
bated in the absence of a cAMP-PDIE inhibitor, the
addition of 1 ,uM AVP elicited a striking (-10 times)
increase in cAMP accumulation (Table VI, Fig. 5,
left panel). No such increase in response to AVP,
however, was seen in MCT of NDI mice (Table VI,
Fig. 5, left panel).
Because we observed a higher activity of cAMP-
PDIE in MCT ofNDI mice than of control mice (Table
V, Fig. 4), we further assessed the effect of cAMP-
PDIE inhibition on cAMP accumulation in the pres-
ence or absence of AVP. Incubation of control MCT
in a medium containing 0.5 mM 1-methyl-3-isobutyl-
xanthine (MIX)2 resulted in markedly higher cAMP
levels compared with basal levels without MIX
2 In a preliminary experiment, 0.5 mM MIX inhibited
cAMP-PDIE activity to a similar extent (-80%) in MAL and
MCT of both control and NDI mice.
TABLE V
Activity of cAMP-PDIE in MCT and MAL from Normal (Control) Mice and Mice wvith NDI
MCT MIAL
Experiment Control NDI Conitrol NDI
1 14.7+0.9* (12) 26.3± 1.4 (11) 16.4+ 1.1 (12) 16.0+ 1.0 (12)
2 7.8±0.4 (12) 24.8+1.8 (12) 10.4+0.5 (11) 15.4±1.4 (12)
3 13.2±+1.9 (6) 29.1±0.7 (6) 17.2+0.9 (5) 20.2±1.7 (6)
4 5.7+0.4 (6) 36.2+2.4 (6) 5.7+0.9 (6) 22.2±+1.6 (6)
5 18.8+ 1.1 (4) 32.3+5.8 (4) 25.5+0.8 (4) 24.6+4.3 (4)
Mean+SEM1 12.0+2.4 29.7+2.lt 15.0+3.3§ 19.7±+1.8"
Enzyme activity is expressed in femtomoles cAMP per min per millimeter tubule length.
* Denotes mean±SEM; number of samples is indicated in parenltheses.
t Significantly different from the control MCT (P < 0.01, paired t test; P < 0.001, group t test).
§ Not significantly different from the control MCT.
"iSignificantly different from MCT of NDI mice (P < 0.001, paired t test; P < 0.01, group t test).
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FIGURE 4 Activity of cAMP-PDIE in MCT (right panel) and
MAL (left panel) in normal (control) mice and mice with
nephrogenic diabetes insipidus NDI. Enzyme activity is ex-
pressed in femtomoles of cAMP per min per microgram of
protein. Each column represents the mean±SEM from five
animals; the value for each animal is the mean of at least four
to six samples. O, control mice; 3, NDI mice; * Value signifi-
cantly higher (P < 0.05; t test) than in control mice, as well as
higher than the value in MAL of NDI mice. Values for
control MCT and control MAL were not significantly dif-
ferent from each other.
(Table VI, Fig. 5, right panel). Addition of 1 ,uM AVP
in the presence ofMIX resulted in an increase in cAMP
level that was much greater than the cAMP level ob-
served in response to AVP or MIX alone (Table VI,
Fig. 5, right panel). In the absence of MIX, the basal
cAMP levels in MCT from NDI mice were slightly but
significantly lower than in MCT of controls, when ex-
pressed per tubular protein (Fig. 5).
The most striking difference between control and
NDI mice was the complete failure ofAVP to increase
cAMP in MCT of NDI mice, in contrast to the striking
stimulatory effect ofAVP in MCT ofcontrol mice (Table
VI, Fig. 5, left panel). Addition of MIX alone caused a
significant increase in the basal cAMP level in MCT
of NDI mice; even more importantly, addition ofAVP
in the presence ofMIX increased cAMP in MCT ofNDI
mice more than three times over the basal level without
MIX (Table VI, Fig. 5, right panel). In the presence
of MIX, the relative cAMP increase in response to AVP
in MCT from NDI mice (3.3 times) was similar to the
3.8-fold increase by AVP in MCT ofcontrol mice (Fig. 5,
right panel). Under all conditions tested, the cAMP
content (picomoles cAMP/microgram protein) in MCT
of NDI mice was significantly lower compared, un-
der corresponding conditions, with MCT of control
mice (Fig. 5).
To learn whether cAMP levels in MCT of NDI mice
could be elevated in response to nonhormonal stimuli
ofadenylate cyclase, the effect ofcholeratoxin, aknown
agonist of adenylate cyclase (34), was briefly tested.
Tubules were incubated with 1 gg/ml cholera toxin
under the same conditions as described in Methods ex-
cept that the incubation time was 60 min instead of
20 min, as used in all other experiments. The pattern
of responses to cholera toxin was similar to that seen
TABLE VI
Effect of Incubation with 1 ,M AVP andlor with 0.5 mM MIX on cAMP Accumulation in MCT and MAL
from Normal (Control) Mice and Mice with NDI
Control mice NDI mice
Experiment Basal AVP MIX MIX + AVP Basal AVP MIX MIX + AVP
MCT
1 3.0±0.1 (2)* 77.5±43.9 (3) 4.9±0.7 (3) 219.9t92.6 (3) 4.4±0.1 (2) 3.9±0.4 (3) 19.1±9.8 (3) 55.6±7.2 (3)
2 1.6±0.2 (3) 71.7±15.2 (3) 11.1±6.8 (3) 26.2±8.8 (3) 2.6±0.6 (3) 3.8±0.4 (3) 11.1±3.4 (3) 22.9±2.5 (3)
3 13.6t3.6 (3) 136.7±29.9 (2) 68.2±16.9 (3) 146.6+13.1 (3) 7.9t 1.1 (3) 8.5±1.0 (3) 12.8±0.6 (3) 22.8±6.2 (3)
4 9.2±1.9 (3) 69.7±24.0 (3) 114.7±37.3 (3) 209.9t60.5 (3) 2.5± 1.0 (3) 2.8±0.9 (3) 6.7± 1.3 (3) 42.7±4.9 (3)
5 4.5±0.4 (3) 111.4±27.8 (3) 24.1 ±4.3 (3) 254.2t7.7 (3) 2.3±0.6 (3) 4.4±1.8 (3) 7.8± 1.1 (3) 46.2± 1.5 (3)
MeantSEM 6.6±1.4 90.3+13.1t 44.6+13.1t 171.4±28.6 t 3.9±0.7 4.6t0.6 11.5t2.1t 38.0±3.9t§
n'' 14 14 15 15 14 15 15 15
MAL
1 2.8±0.9 (4) 3.5±0.5 (6) 3.5t0.5 (2) 2.9±0.9 (3) 2.4±0.3 (3) 3.3± 1.0 (3) 3.2±0.7 (3) 16.3±7.6 (3)
2 1.8±0.1 (2) 2.6±1.2(3) 2.0±0.4(3) 2.9±1.0(3) 4.7±0.5(3) 7.4±0.6(3) 6.2±0.9(3) 6.1±0.4(3)
3 7.2±2.3 (2) 6.3±0.8 (3) 6.2±3.2 (3) 13.1±5.4 (3) 7.9±1.0 (3) 6.8±1.3 (3) 5.8±0.6 (3) 7.1±0.1 (3)
4 5.0±1.4 (3) 5.3± 1.0 (2) 12.3± 1.9 (3) 14.3± 1.5 (3) 7.2t0.4 (3) 7.3t0.9 (3) 7.0± 1.2 (3) 7.4± 1.5 (3)
5 3.7±0.5 (3) 3.9±0.8 (3) 3.7±0.4 (3) 6.7±0.9 (3) 7.1±0.8 (3) 7.4±1.5 (3) 7.6±1.2 (3) 7.8±0.5 (3)
Mean+SEM 3.9±0.6 4.1t0.4 5.7+1.2 7.6t1.5 5.9t0.6 6.5t0.6 5.9t0.5 8.9±1.6
n 14 17 14 15 15 15 15 15
All values are expressed in femtomoles cAMP per millimeter tubule length (for details see Methods).
* Denotes meantSEM; number of samples is indicated in parentheses.
Denotes value significantly different (P < 0.01 or higher level of significance; t test) from basal.
§ Denotes value significantly different from MIX alone or AVP alone (P < 0.02 or higher level of significance; t test).
n, total number of samiiples.
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FIGURE 5 Effect of 1 ,zM AVP and of 0.5 mM MIX on the cAMP content (expressed in femto-
moles of cAMP per microgram of protein) of MCT in normal (control) mice and mice with NDI.
B, basal value; AVP, content in the presence of 1 ,tM AVP. Each bar represents the mean +SEM
of 14-15 samples dissected from five control and five NDI mice. O, control mice; 0, NDI mice.
Left panel: incubations in the absence of MIX; right panel: incubations in the presence of
0.5 mM MIX. The basal cAMP level in MCT of NDI mice was significantly lower (P < 0.02;
t test) than in MCT of control mice. Levels of cAMP in MCT of either control or NDI mice in
the presence of MIX (right panel) were always significantly (P < 0.01; t test) higher than
corresponding values of MCT incubated in the absence of MIX (left panel).
with AVP. In preliminary experiments, we observed
that incubation ofMCT from control mice with cholera
toxin alone caused a marked accumulation of cAMP,
similar to that achieved with AVP (data not shown).
When incubated in the presence of MIX, cholera toxin
induced about the same cAMP accumulation as AVP
and MIX in control MCT (Table VII). In MCT of NDI
mice, cholera toxin plus MIX also increased levels of
cAMP to about the same extent as AVP plus MIX;
however, as with AVP, the levels of cAMP that ac-
cumulated in MCT of NDI mice in response to cholera
toxin alone were much lower than in MCT of control
mice (Table VII).
Basal cAMP levels were not different between MAL
of NDI mice and controls (Table VI). Levels of cAMP
in MAL of either control or NDI mice did not change
in response to AVP whether or not MIX was present
(Table VI). The pattern of results was the same when
expressed per micogram of tubular protein. Similarly,
incubation with cholera toxin had no effect on cAMP
TABLE VII
Effects of Incubation with 1 ,uM AVP and 1 Hg/rnl Cholera Toxin (CT) in the
Presence of 0.5 mM MIX on cAMP Accumulationt in MCT
of Normal (Control) Mice and Mice with NDI
MIX MIX + AVP MIX + CT
Control 91.4+21.1* (6) 178.3+31.1t (6) 160.8+30.4 (6)
NDI 11.9+1.6§ (6) 22.8+2.9t§ (6) 28.3+8.6§ (6)
cAMP levels are expressed in femtomoles per millimeter tubule length.
* Denotes mean+SEM; numbers in parentheses indicate the number of samples.
4 Significantly higher (P < 0.05 or less; t test) than cAMP level with MIX alone.
§ Significantly lower (P < 0.005 or less; t test) than corresponding control value
from control mice.
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levels in MAL of either control or NDI mice (data
not shown).
DISCUSSION
Results from our previous study (4) suggested that the
renal concentrating defect in mice with hereditary
NDI is associated with an abnormal VP-dependent
metabolism of cAMP. Further analysis of this defect in
specific segments of the nephron was necessary, for a
number of reasons.
As shown by Chabardes et al. (15) and confirmed in
the present experiments, VP-sensitive adenylate
cyclase in the mouse kidney is present not only in
collecting tubules but also in the ascending limb of
Henle's loop. In rat outer medulla, MAL outnumber
MCT by a factor of about 5:1 (20, 35). According to
our present observations, because a similar or even
higher ratio holds for the outer medulla of the mouse
kidney, it is likely that most of the adenylate cyclase
activity measured in homogenates prepared from
mouse medulla represents predominantly adenylate
cyclase from the ascending limbs of Henle's loops,
whereas only a small proportion is derived from the col-
lecting tubules. Although the VP-sensitive cAMP sys-
tem in the MAL may contribute to dilution of tubular
fluid in this segment (17, 18) and increase medullary
osmolarity (36), the basic role ofVP required for forma-
tion of hypertonic urine (the control of water permea-
bility through cAMP as a "second messenger") (37) has
been found (6) and confirmed (7, 31, 38) only in collect-
ing tubules (37). Moreover, although a highly active
VP-sensitive adenylate cyclase has been found in the
collecting tubules of all mammalian species examined
to date (16), the VP-sensitive adenylate cyclase in the
MAL, in contrast, appears to be less active in some
species than in others (16) and, to date, has not been
detected in the human kidney (16, 39). These con-
siderations suggest that a concentrating defect such as
in NDI mice can only be identified by separately ex-
amining the VP-sensitive cAMP system in collecting
tubules and in the ascending limbs of Henle's loops.
The major observation in the present experiments is
the striking difference in cAMP levels in MCT ac-
cumulated in response to AVP. The complete lack of
cAMP response to AVP in MCT from NDI mice
(especially when compared with the more than 10-
fold increase in MCT ofcontrol mice), strongly suggests
that this is the primary defect and cellular basis for the
unresponsiveness of NDI mice to AVP in vivo (1, 3, 4,
10). Even if additional defect(s) in the cellular action
ofVP in steps (known or putative) subsequent to cAMP
accumulation (5) should be uncovered in future studies,
the complete absence of a cAMP increase in response
to AVP in MCT (Fig. 5, Table VI) in itself can explain
the functional unresponsiveness to the hormone.
Unresponsiveness ofMCT from NDI mice to AVP is
apparently the result ofa combination ofseveral factors;
higher cAMP-PDIE activity and lower adenylate
cyclase. Lower activity of AVP-sensitive adenylate
cyclase could be observed in MCT of NDI mice only
when expressed per unit protein (Fig. 3, right panel),
but not when related to tubular length (Table III).
Moreover, adenylate cyclase in MCT of NDI mice
did not differ from MCT of control mice in relative
sensitivity (%A increase over basal) to AVP, NaF, or
Gpp(NH)p; the absolute (net) increase of adenylate
cyclase in response to NaF or Gpp(NH)p was lower,
although not statistically significant, in MCT of NDI
compared with control mice. The concentration ofAVP
required for half-maximal stimulation of adenylate
cyclase, which likely reflects affinity for AVP (40),
does not appreciably differ between NDI and control
mice (Fig. 2). An abnormally high requirement of
adenylate cyclase for GTP (33) seems to be ruled out.
These features would suggest a defect in the catalytic
subunit of adenylate cyclase, which is not specifically
related to AVP effect. Although such a partial alteration
in the properties of adenylate cyclase might contribute
to the lower basal level of cAMP in MCT of NDI
mice, it cannot explain the total inability of AVP to
increase cAMP levels (Fig. 5, Table VI).
Higher cAMP-PDIE activity in MCT of NDI mice is
likely to be a major factor in the unresponsiveness to
VP. This is emphasized by the observation that MIX
not only increased basal cAMP levels, but also restored
the responsiveness of MCT to VP (Fig. 5). This higher
specific activity of cAMP-PDIE suggests that cAMP is
catabolized in MCT of NDI mice at a higher rate than
in control animals. However, conditions for cAMP
breakdown in situ almost certainly differ from those
observed in vitro; hence, the actual quantitative dif-
ferences in cAMP catabolism may be even more promi-
nent in intact cells.
These findings suggest that an abnormally high rate
of cAMP breakdown in MCT of NDI mice prevents
increases in cAMP even after stimulation with high
doses of AVP. Although treatment with MIX restored
the %A responsiveness of MCT to AVP to approxi-
mately the same degree as that seen in MCT of control
mice in the presence ofMIX (about three-fold increase;
Fig. 5, right panel), the absolute amount of cAMP
accumulated in MCT from NDI mice is substantially
lower than in MCT from control mice. The observa-
tions that accumulation of cAMP in response to MIX
alone (Table VI, Fig. 5) or to cholera toxin (Table VII)
are also much lower in MCT of NDI mice indicates
that the observed defect does not only relate to the
cAMP pool that is controlled by AVP. In addition to
lower adenylate cyclase activity and higher cAMP-
PDIE activity in MCT ofNDI mice, other factors could
possibly play additional roles. For example, in intact
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NMCT of NDI mice, the intracellular pool of ATP
serving as substrate for cANIP generation may be ab-
normally low, and/or some co-factors of the adenylate
cyclase system such as GTP, magnesium, or others,
may be depleted.
The major abnormality found in MIAL of NDI mice is
a markedly lower activity of adenylate cyclase. Al-
though this deficiency is much more pronounced
than that observed in MCT, the major features are
similar because the adenylate cyclase activity is low
in MAL of NDI mice, both under basal conditions or
after maximal stimulation with AVP (Table III, Fig. 3,
left panel), NaF (Table IV), or Gpp(NH)p. As for the
MCT, the affinity ofthe AVP receptor is not diminishedl
in the MAL of NDI mice. The inability to restore
VP-sensitive adenylate cyclase activity in MAL of NDI
mice to normal by addition of GTP also argues against
the possibility that the abnormality lies in the guanyl
nucleotide site (33).
When dissected from the same animal as MCT and
tested under exactly the same conditions, the MIAL
froml either control or NDI animals did not respond to
AV'P, MIX, or to cholera toxin (data not showni) by
a change in cAMP levels. This total unresponsiveness
is not the result of the absence of VP-sensitive
adenylate cyclase (Table III, Fig. 3) to excessively
high cAMP-PDIE (Table V, Fig. 4) or the resistance of
cAMP-PDIE to MIX.2 Using the same preparative and
assay conditions, we found consistent increases of
cAMP in response to AVP in MAL dissected from the
rat medulla (13, 41). This would suggest that the unre-
sponsiveness in the MAL of mice may be the result
of some as yet unknown feature that is peculiar to
mouse MAL. Because the sensitivity ofMAL adenylate
cyclase to VP is well preserved, it does not appear prob-
able that damage to the cell surface in MAL is a major
factor in the VP unresponsiveness. It seems more likely
that the mouse MAL may be vulnerable to depletion of
some important co-factor(s) necessary for itn situ cANIP
formation, which might result from microdissecting
and testing procedures that we currently employ. For
example, ATP and/or GTP could be depleted during
preparation. According to a recent report, ATPase ac-
tivity in MAL is much higher than in MCT (42); this
feature could make MAL more prone to depletion of
nucleoside-5'-triphosphates.
The question may arise whether the observed altera-
tions of the VP-sensitive cAMP system, in MCT, may
be the consequence of polyuria rather than a primary,
causative factor. Several observations argue against
such a possibility. We previously observed that in rats
with polyuria induced by potassium depletioni, VP-
induced cAMP accumulation in MCT is normal (or
even higher) than in controls (41). Likewise, in poly-
uria induced by administration of lithium, the activities
of basal and VP-stimulated adenylate cyclase or of
cANIP-PDIE in MICT and NIAL were not different
from controls (43). In MICT from normal (control) mice
in which polyuria was iniduced by drinking 5% glu-
cose, VP readily elicited an inerease in cAMP.3 These
observations in polyuric states of diverse etiology arguie
strongly against the possibility that abnormiialities of
cANIP metabolism in NDI mice are secondary
to polyuria.
Comparison of present findings with our previous
study (4) should be briefly considered. It should be
realized that in the past study (4) the preparations
were from whole medulla and papilla taken together,
whereas the present study was localized to MICT and
MAL, anid also that enzyme assays differed at cer-
taini points.
Because MAL is numerically the predominiaint VP-
sensitive tubular segmiienit in the medulla (20, 35), it
is likely that lower VP-stimulated adenylate cyclase
activity in preparations from the whole medulla (4)
reflected the lower activity of adenylate cyclase in
NIAL (Table III, Fig. 3). As in the previous study (4),
the apparent affinity of adenylate cyclase for VP (Fig.
2) is not alteredl in NDI mlice. In the preceeding
study, we found no differenice in basal and NaF-stimu-
lated activity while these activities were lower in MCT
and MIAL of NDI mice (Fig. 1, Table IV). It should
be realized that adenylate cyclase (basal or nonspeci-
fically stimulated by NaF) is a ubiquitous enzyme
presenit in all cell types, whereas VP-sensitive adenyl-
ate cvclase in mouse renal meldulla is limited to MAL
and NICT (15, 16). Thus, the basal activity and NaF-
stimulated activity derived from MAL and MCT were
admixed in whole medulla preparations with mem-
branes from all other cell types, preventing detectioni of
significaint differences.
The abnormally high activity of cAMIP-PDIE of NDI
mice (Fig. 4, Table V) probably went undetected in
the past study for two reasons. First, the difference
in cAMIP-PDIE activity is limited to MCT and this
nephroii segment contributes little to total cell mass
(35) in nmedulla. Second, in preparations from the whole
medulla, eAMIP-PDIE was assayed only in the cytosol
(4) and at a substrate conicenitration of 0.5 mM cAMP,
which likelv reflects mainly low-affinity, high Km
cAMIP-PDIE (44). In the present stuidies oIn isolated
tubules, 1 /iM cAM1P substrate was used to pre-
3Polyuria was induced in control mice by allowinig them
to drink 5% glucose instead of tap water for 6-10 d (4).
Urinary output increased from 0.85±0.2 to 15.0±1.9 (ml/24 h;
iiiean±SE) and urine osinolality decreased from 3,556+97
to 436+83 (iiosmiiol/lkg H20; mi<ean+SE). In MCT micro-
dissected fromn polyuric mice 1 uNI AVP elicited a cANIP
increase analogous to that in control iice (Table VI).
Basal level was: 5.5+1.5 (fmol cANIP/mm); and vith AVP
significantly (P < 0.001, t test) higher: 90.1±11.9 (fmiol
cANIP/min).
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dominantly detect the high-affinity, low-Km variety of
cAMP-PDIE (23, 44). Present results are, therefore,
not only quite compatible with the previous study
(4), but also emphasize the need for analysis of specific
nephron segments to exactly localize the abnormalities
in VP action.
The present observations not only provide new in-
sights into the pathogenesis of hereditary NDI in mice,
but also illustrate the importance of studying all as-
pects of cAMP metabolism in specific nephron seg-
ments separately. The results also stress the importance
of cAMP-PDIE in the cellular dynamics of cAMP.
Thus, even when no difference in VP-sensitive
adenylate cyclase (expressed per tubule length) could
be detected, nevertheless, a complete unresponsive-
ness of MCT to AVP (assessed as cAMP accumulation)
may occur.
In conclusion, the results of the present study sug-
gest that the lack of an antidiuretic response to VP in
NDI mice in vivo may be the result of impaired VP-
sensitive cAMP metabolism in collecting tubules,
specifically an inability to increase cAMP levels in re-
sponse to AVP. This inability results perhaps partly
from lower stimulation of MCT adenylate cyclase by
AVP, but mainly from abnormally high cAMP-PDIE ac-
tivity in MCT of NDI mice. A defect of adenylate
cyclase in MAL may also conceivably contribute to
the urinary concentrating defect in this experimental
model of NDI by decreasing the buildup of inter-
stitial gradient of solutes.
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